Research shows TensGuard from Dutch firm DSM is effective under pressure

A recent clinical trial conducted by TNO, a leading independent Dutch research organization, shows that Netherlands-based life science firm DSM's breakthrough dairy peptide ingredient, TensGuard, successfully lowers systolic and diastolic blood pressure in people with mild hypertension. These results will be welcome news for functional food and dietary supplement manufacturers looking for effective ingredients to tap into the growing market for blood pressure management products, says the company.

The study was a randomized, placebo-controlled, double-blind crossover trial involving 80 subjects all aged between 30 and 70. All participants were pre-hypertensive or at stage 1 hypertension at the start of the trial, as assessed at pre-study screenings. The subjects were all given a course of capsules containing either TensGuard or a placebo. They consumed two of these daily for a period of four weeks - one after breakfast and one after the evening meal.